• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Picker notches strong profit growth

Article

Multimodality vendor Picker International's 1998 financial results indicated double-digit growth rates for both revenues and profits, the Cleveland company reported last month. The company posted revenue of $1.24 billion for fiscal 1998 (end-March), up

Multimodality vendor Picker International's 1998 financial results indicated double-digit growth rates for both revenues and profits, the Cleveland company reported last month. The company posted revenue of $1.24 billion for fiscal 1998 (end-March), up 11.5% compared with sales of $1.1 billion for fiscal 1997. Picker's equipment order backlog increased by 20%.

Profits before tax also climbed, at a rate of 19%, although Picker is not required to release specific net income numbers because it is a subsidiary of General Electric Company (GEC) of the U.K. Picker executives attributed the strong growth to the rebound in the medical imaging market, as well as new products released in 1997, overseas growth, and expanded services and businesses.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.